{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:01:17Z","timestamp":1763751677247,"version":"3.45.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nefroe.2025.501357","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:54:53Z","timestamp":1763751293000},"page":"501357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From stage 1 to end-stage renal failure: Amyloid \u03b242, amyloid \u03b240, amyloid \u03b242\/40 ratio, p-tau181 and cognitive function relationship"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-9003","authenticated-orcid":false,"given":"Yasemin","family":"Co\u015fkun Yavuz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Biyik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-8777","authenticated-orcid":false,"given":"Firdevs","family":"Sak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9524-6115","authenticated-orcid":false,"given":"Muslu","family":"Kaz\u0131m Korez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedat","family":"Abusoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutfullah","family":"Altintepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2025.501357_bib0140","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/ndt\/gfl275","article-title":"Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study","volume":"21","author":"Kurella","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2025.501357_bib0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14283\/jpad.2020.21","article-title":"Early detection of mild cognitive impairment (MCI) in primary care","volume":"7","author":"Sabbagh","year":"2020","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.nefroe.2025.501357_bib0150","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.nefroe.2025.501357_bib0155","doi-asserted-by":"crossref","first-page":"e210225","DOI":"10.1212\/WNL.0000000000210225","article-title":"Blood-based biomarkers and risk of onset of mild cognitive impairment over the short and long term","volume":"104","author":"Soldan","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.nefroe.2025.501357_bib0160","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1007\/s12035-015-9218-y","article-title":"Factors responsible for plasma \u03b2-amyloid accumulation in chronic kidney disease","volume":"53","author":"Gronewold","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.nefroe.2025.501357_bib0165","doi-asserted-by":"crossref","first-page":"2726369","DOI":"10.1155\/2017\/2726369","article-title":"Cognitive impairment in chronic kidney disease: vascular milieu and the potential therapeutic role of exercise","volume":"2017","author":"Bronas","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.nefroe.2025.501357_bib0170","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jgs.16954","article-title":"Kidney function and cognitive decline in older adults: examining the role of neurodegeneration","volume":"69","author":"Guerville","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nefroe.2025.501357_bib0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.nefroe.2025.501357_bib0180","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nefroe.2025.501357_bib0185","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/ndt\/gfab182","article-title":"Association of renal impairment with cognitive dysfunction in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA)","volume":"36","author":"Paterson","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2025.501357_bib0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1590\/2175-8239-jbn-2018-0086","article-title":"Montreal Cognitive Assessment for cognitive assessment in chronic kidney disease: a systematic review","volume":"41","author":"Amatneeks","year":"2019","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.nefroe.2025.501357_bib0195","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/23279095.2020.1778477","article-title":"Cognition in chronic kidney disease patients: evaluation with the Beijing version of the Montreal Cognitive Assessment","volume":"29","author":"An","year":"2022","journal-title":"Appl Neuropsychol Adult"},{"key":"10.1016\/j.nefroe.2025.501357_bib0200","first-page":"273","article-title":"Reliability and validity of the standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population","volume":"13","author":"G\u00fcngen","year":"2002","journal-title":"Turk Psikiyatri Derg"},{"key":"10.1016\/j.nefroe.2025.501357_bib0205","first-page":"166","article-title":"Power of discrimination of Montreal Cognitive Assessment (MOCA) scale in Turkish patients with mild cognitive impairement and Alzheimer's disease","volume":"13","author":"Selekler","year":"2010","journal-title":"Turk Geriatri Dergisi"},{"key":"10.1016\/j.nefroe.2025.501357_bib0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0891988714522701","article-title":"Validation of Montreal Cognitive Assessment and discriminant power of Montreal Cognitive Assessment subtests in patients with mild cognitive impairment and Alzheimer dementia in Turkish population","volume":"27","author":"Kaya","year":"2014","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.nefroe.2025.501357_bib0215","doi-asserted-by":"crossref","first-page":"106626","DOI":"10.1016\/j.nbd.2024.106626","article-title":"Kidney\u2013brain axis in the pathogenesis of cognitive impairment","volume":"200","author":"Yan","year":"2024","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nefroe.2025.501357_bib0220","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer's disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nefroe.2025.501357_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9113452","article-title":"Diagnostic utility of selected serum dementia biomarkers: amyloid \u03b2-40, amyloid \u03b2-42, tau protein, and ykl-40: a review","volume":"9","author":"Wilczy\u0144ska","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.nefroe.2025.501357_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom14010093","article-title":"Blood biomarkers of Alzheimer's disease and cognition: a literature review","volume":"14","author":"Garcia-Escobar","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.nefroe.2025.501357_bib0235","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1007\/s12035-016-0243-2","article-title":"Association of plasma \u03b2-amyloid with cognitive performance and decline in chronic kidney disease","volume":"54","author":"Gronewold","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.nefroe.2025.501357_bib0240","doi-asserted-by":"crossref","first-page":"e13239","DOI":"10.1111\/acel.13239","article-title":"Klotho overexpression improves amyloid-\u03b2 clearance and cognition in the APP\/PS1 mouse model of Alzheimer's disease","volume":"19","author":"Zhao","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.nefroe.2025.501357_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms25084194","article-title":"Cognitive impairment related to chronic kidney disease is associated with a decreased abundance of membrane-bound klotho in the cerebral cortex","volume":"25","author":"Rodr\u00edguez-Ortiz","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nefroe.2025.501357_bib0250","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/alz.12466","article-title":"Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities","volume":"18","author":"Syrjanen","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.nefroe.2025.501357_bib0255","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-2011-111418","article-title":"Evaluation of plasma A\u03b2 as predictor of Alzheimer's disease in older individuals without dementia: a population-based study","volume":"28","author":"Hansson","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nefroe.2025.501357_bib0260","first-page":"44","article-title":"Analysis of levels of Vitamin D, beta-amyloid 42, indoxyl sulfate, and serum parathyroid hormone in hemodialysis patients with cognitive impairment","volume":"21","author":"Syafrita","year":"2024","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.nefroe.2025.501357_bib0265","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/ckj\/sfad173","article-title":"Plasma A\u03b2(42):A\u03b2(40) ratio as a biomarker for cognitive impairment in haemodialysis patients: a multicentre study","volume":"16","author":"Chen","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2025.501357_bib0270","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3904\/kjim.2021.492","article-title":"Emotional and cognitive changes in chronic kidney disease","volume":"37","author":"Kim","year":"2022","journal-title":"Korean J Intern Med"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251425001646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251425001646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:55:23Z","timestamp":1763751323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251425001646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2013251425001646"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.501357","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From stage 1 to end-stage renal failure: Amyloid \u03b242, amyloid \u03b240, amyloid \u03b242\/40 ratio, p-tau181 and cognitive function relationship","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.501357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Nefrolog\u00eda.","name":"copyright","label":"Copyright"}],"article-number":"501357"}}